Soligenix Inc. updates its Medical Advisory Board for CTCL treatment development, NeuroOne Medical Technologies strengthens its patent portfolio for electrode devices, and Centenario Gold Corp. signs a Letter of Intent to acquire the Cabot Copper and Gold Project. Additionally, a new scientific statement emphasizes the barriers women face in accessing cardiac rehabilitation programs, while BioMed X launches XFem Labs, a Women’s Health R&D Accelerator supported by the Gates Foundation, focusing on innovative solutions for women's health.
